
iShares U.S. Pharmaceuticals ETF
IHE
Updated: 22/09/2026, 19:38:45
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
No summaries found.
- Share price
- $102.62
- Market cap
- $1.16B
- Exchange
- AMEX
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 05/05/2006
- Beta
- 0.497
- Last dividend
- $0.00
- Day range
- $101.30 – $103.20
- 52-week range
- $69.02 – $108.66
- 1-day performance
- 0.37%
- 1-year performance
- 48.68%
- Current drawdown (1Y)
- -5.56%
- CIK
- 0001100663
- CUSIP
- 464288836
- ISIN
- US4642888360
- Created
- 07/12/2025, 04:42:04
- Last update
- 22/09/2026, 19:38:45
Track iShares U.S. Pharmaceuticals ETF with an AI analyst
See which prediction-market events move IHE, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
24/7 Wall Street • STOCK • 19/05/2026, 18:19:54
IHE: Healthcare Dashboard For May
Seeking Alpha • STOCK • 16/05/2026, 12:42:43
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks Investment Research • STOCK • 11/05/2026, 09:21:09
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks Investment Research • STOCK • 09/03/2026, 08:21:23
IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features
Seeking Alpha • STOCK • 27/02/2026, 17:18:00